The Soleus Pushup: How a Seated Calf Exercise Slashes Blood Sugar
The soleus pushup reduces postprandial blood glucose by up to 52% and insulin demand by approximately 60%, effects that rival or exceed those of walking or pharmacological agents.
The soleus works through contraction-stimulated GLUT4 translocation via AMPK, a pathway that bypasses the insulin receptor entirely and does not deplete local glycogen stores.
Sedentary time is an independent metabolic risk factor, and the soleus pushup addresses it without requiring any disruption to desk-based work or cognitive tasks.
The movement is only effective when performed seated with knees bent at 90 degrees, isolating the soleus and not the glycolytic gastrocnemius.
Long-term randomized trials do not yet exist, but the acute effect size is large, the mechanism is well-established, and the risk profile is effectively zero.
The soleus pushup is complementary to, not competitive with, pharmacological metabolic interventions such as metformin, SGLT2 inhibitors, and GLP-1 agonists.
Practicing the movement during the postprandial window, starting within 30 minutes of a meal, targets the period of peak glucose excursion and maximum potential benefit.
Most exercise recommendations for metabolic health involve getting up, getting moving, and elevating the heart rate. The soleus pushup breaks that assumption entirely. Published in iScience in 2022, a study from the University of Houston demonstrated that a simple, repetitive seated calf movement can reduce postprandial blood glucose by up to 52% and lower insulin demand by approximately 60%, outperforming the metabolic effects of walking, running, and some pharmaceutical interventions, all without leaving a chair. [1] The implications ripple well beyond gym-goers. For the hundreds of millions of people living with elevated blood glucose, insulin resistance, or type 2 diabetes, and for the longevity-minded individual trying to avoid those outcomes entirely, the soleus pushup represents a genuinely novel tool, one that operates through mechanisms most exercise physiologists had not previously considered.
Understanding why this small movement produces outsized metabolic effects requires a short detour into muscle biology, specifically the soleus muscle, which sits quietly beneath the more famous gastrocnemius and rarely receives the attention its metabolic importance warrants. The soleus is not just another calf muscle. It is, by several measures, one of the most metabolically active tissues in the human body, and the way it derives energy sets it apart from virtually every other skeletal muscle. The story of the soleus pushup is, at its core, the story of a muscle that has been hiding in plain sight.
The Soleus: A Metabolic Engine in Disguise
Skeletal muscle accounts for roughly 40% of body mass in a typical adult and is the dominant site of glucose disposal after a meal. [2] When blood glucose rises following eating, insulin signals muscle cells to take up glucose from the bloodstream, converting it to glycogen for storage or oxidizing it for energy. This insulin-stimulated glucose uptake is the primary mechanism by which the body clears postprandial glucose spikes, and its impairment is the defining feature of type 2 diabetes. What makes the soleus unusual is that it can sustain this glucose uptake through a pathway that does not depend on glycogen stores being depleted first.
Most skeletal muscles are glycolytic under moderate to heavy load: they burn glucose and store it as glycogen, then tap that glycogen when needed. The soleus, by contrast, is composed predominantly of slow-twitch, oxidative muscle fibers, the type designed for sustained, low-intensity contractions over very long periods. Think of the difference between a sprinter's quadriceps and a marathon runner's soleus: the former exhausts quickly, relying on anaerobic glycolysis; the latter operates continuously, drawing on oxidative metabolism like a diesel engine rather than a gasoline one. [3] This oxidative profile means the soleus preferentially burns fuel using mitochondria, the cellular organelles that convert glucose and fat into ATP, the molecular currency of energy.
Critically, the soleus has a remarkable capacity for what researchers call non-insulin-mediated glucose uptake. Most muscle glucose uptake after a meal is driven by insulin binding to its receptor on the muscle cell surface, triggering a cascade that moves glucose transporter proteins, primarily GLUT4, to the cell membrane. But the soleus can also activate GLUT4 translocation through muscle contraction itself, independently of insulin. [4] This contraction-stimulated pathway operates through AMP-activated protein kinase (AMPK), a cellular energy sensor that acts like a fuel gauge: when energy is being used, AMPK signals the cell to take up more fuel. During a soleus pushup, this pathway is continuously activated because the muscle is continuously contracting, even at very low intensity.
The result is a sustained, low-level metabolic drain on blood glucose that does not require the pancreas to secrete more insulin. The muscle becomes, in effect, an always-on glucose sink, quietly clearing the bloodstream without the hormonal spikes and crashes that accompany more intense exercise. This is a fundamentally different kind of metabolic activity from what most people associate with exercise.
The 2022 Study: What the Researchers Actually Found
The landmark investigation, led by Marc Hamilton at the University of Houston, was specifically designed to measure what happens to systemic metabolism when the soleus is activated continuously during the kind of prolonged sitting that characterizes modern desk work. [1] Participants performed the soleus pushup for up to 270 minutes while seated, a duration chosen to simulate a typical desk-bound workday. The movement itself is simple: while seated with feet flat on the floor, the heel rises while the ball of the foot stays planted, engaging the soleus, then the heel lowers back down. This is repeated continuously, at a self-selected pace, with minimal perceived exertion.
The soleus pushup reduced postprandial blood glucose by 52% and insulin demand by approximately 60%, effects that exceed those of walking or running and rival some pharmaceutical interventions.
The metabolic data were striking. Blood glucose area under the curve following a standard oral glucose challenge was reduced by approximately 52% in participants performing the soleus pushup compared to sitting quietly. [1] Insulin response, measured as the area under the insulin curve over the same period, fell by around 60%. These are not modest improvements. The magnitude of glucose reduction rivals or exceeds the effect of a brisk walk, a well-established postprandial intervention, and the insulin-sparing effect is particularly significant because chronically elevated insulin is itself a driver of metabolic dysfunction, driving fat storage, inflammation, and cardiovascular risk.
The researchers also measured VLDL triglycerides, the lipid particles associated with cardiovascular risk and often elevated in metabolically unhealthy individuals. Soleus pushup activity reduced VLDL triglyceride disposal rates substantially, suggesting that the muscle's metabolic activity extended beyond glucose to include lipid metabolism. [1] Importantly, the metabolic effects persisted throughout the prolonged activity period, with no evidence of fatigue or diminishing returns at the muscle level, consistent with the soleus's oxidative, fatigue-resistant fiber composition.
One methodological nuance deserves emphasis: this was a study of acute metabolic responses, not a long-term randomized controlled trial. The study design demonstrates that the soleus pushup changes blood glucose and insulin dynamics on a single occasion, not necessarily that it improves fasting glucose or HbA1c over months. That distinction matters for interpreting the evidence honestly. What the data do establish, convincingly, is that this specific muscle activation during prolonged sitting produces a real and quantifiable metabolic benefit in the postprandial window, which is precisely the window when elevated glucose causes the most cumulative vascular damage.
Why Prolonged Sitting Is the Right Context to Understand This
Sedentary time is not simply the absence of exercise. Research now treats it as an independent metabolic risk factor, one that persists even in individuals who meet standard physical activity guidelines. [5] A person who runs five kilometers in the morning and then sits at a desk for eight hours has a metabolic profile that differs meaningfully from someone who is moderately active throughout the day. The interruptions matter. Even brief bouts of light activity, standing, walking to the kitchen, pacing during a phone call, attenuate postprandial glucose spikes in ways that a single morning workout cannot fully replicate. [6]
The soleus pushup fits into this framework as a practical solution to an architectural problem. Desk-bound work, long meetings, air travel, hours of screen time, these are features of modern life that are not disappearing. Recommending that people stand up every 30 minutes is sound advice, but compliance is poor and the social context often makes it impractical. A movement performed invisibly while seated, with no equipment and no disruption to cognitive work, solves the compliance problem that undermines most sedentary-reduction interventions.
From a longevity perspective, the stakes are high. Postprandial hyperglycemia, defined as blood glucose spikes above 140 mg/dL after meals, is associated with increased risk of cardiovascular disease, retinal damage, and cognitive decline, even in individuals who do not meet criteria for diabetes. [7] Glycemic variability, the pattern of peaks and troughs in blood glucose throughout the day, independently predicts oxidative stress and vascular endothelial injury. [8] Blunting those peaks, meal after meal, year after year, compounds into meaningful long-term protection. The soleus pushup, practiced consistently at meals, could represent exactly this kind of low-effort, high-frequency metabolic intervention.
The Muscle Contraction Pathway: AMPK and the Insulin-Independent Route
To appreciate why the soleus pushup works so much better than expected for such a low-intensity movement, it helps to understand the two distinct pathways through which skeletal muscle takes up glucose. They run in parallel, like two lanes of a highway, and they can be activated independently or together.
The first lane is the insulin-dependent pathway. After a meal, rising blood glucose triggers pancreatic beta cells to secrete insulin. Insulin binds to receptors on muscle cell surfaces, activating a signaling cascade through IRS-1 and PI3-kinase that ultimately causes GLUT4 transporter vesicles to migrate from inside the cell to the cell membrane, where they allow glucose to enter. This is the primary mechanism of postprandial glucose clearance and the one that fails in type 2 diabetes. [9]
The second lane is the contraction-stimulated pathway, activated by physical movement itself. When a muscle contracts, ATP is consumed, and the ratio of AMP to ATP rises. AMPK, functioning like an intracellular energy alarm, detects this ratio and activates GLUT4 translocation through a pathway that bypasses the insulin receptor entirely. [4] This is why exercise lowers blood glucose even in people with severe insulin resistance: the muscle doesn't need insulin's signal when contraction provides its own.
The soleus's advantage is that its oxidative fiber composition keeps this AMPK pathway active throughout sustained, low-intensity contraction without depleting local glycogen stores. In glycolytic muscles, prolonged activity depletes glycogen, which eventually attenuates the AMPK signal. The soleus, running primarily on oxidative metabolism and drawing on circulating glucose and fatty acids rather than stored glycogen, can sustain AMPK activation for hours. [3] It is, metabolically speaking, the ideal tissue for prolonged low-grade glucose clearance.
There is also a vascular dimension. The soleus muscle is richly perfused: its capillary density, the number of capillaries per unit of muscle tissue, is among the highest in the body, reflecting its role as a continuously active postural muscle. During soleus pushups, local blood flow increases substantially, improving the delivery of glucose to the muscle and enhancing the rate at which it can be cleared from the bloodstream. [1] This enhanced perfusion amplifies the AMPK-driven glucose uptake effect, creating a compounding mechanism rather than a single isolated action.
Comparing the Soleus Pushup to Other Postprandial Interventions
The metabolic literature on postprandial glucose management offers several established strategies: postmeal walking, resistance exercise, dietary fiber intake, and pharmacological agents including metformin and SGLT2 inhibitors. Placing the soleus pushup within this landscape requires both honesty about what the single acute study can claim and recognition of what the magnitude of effects implies.
A brisk 15-minute walk after a meal reduces postprandial glucose by approximately 20 to 30% in individuals with type 2 diabetes and somewhat less in healthy individuals. [10] The 52% reduction observed with the soleus pushup, achieved over a longer window but without increasing heart rate or requiring displacement from a seated position, represents a larger effect. This comparison is not entirely apples-to-apples: the glucose challenge timing, the participant characteristics, and the measurement windows differ between studies. But the order of magnitude of the soleus pushup's effect is notable and warrants the attention it has received.
Pharmacologically, metformin reduces fasting glucose and HbA1c through hepatic mechanisms, primarily suppressing glucose production by the liver, and has modest effects on postprandial excursions specifically. [11] SGLT2 inhibitors, which force the kidneys to excrete excess glucose in urine, do reduce postprandial glucose but through a mechanism that involves glycosuria and modest caloric loss rather than improved muscle glucose disposal. [12] GLP-1 receptor agonists slow gastric emptying and stimulate insulin secretion, reducing postprandial spikes substantially, but require injection or oral dosing. None of these pharmacological approaches replicate the specific mechanism of contraction-stimulated GLUT4 translocation that the soleus pushup engages.
Unlike pharmacological interventions, the soleus pushup activates glucose clearance through the muscle's own contraction-stimulated machinery, requiring no insulin, no medication, and no disruption to cognitive work.
This is not an argument against pharmacotherapy for metabolic disease: medications like metformin, acarbose, and canagliflozin remain foundational tools for managing insulin resistance and reducing long-term cardiovascular and metabolic risk in appropriate clinical contexts. The point is that the soleus pushup activates a distinct and complementary mechanism, one that does not compete with pharmacological approaches but could augment them. The two lanes of the glucose-clearance highway can carry traffic simultaneously.
Practical Application: How to Perform the Soleus Pushup Correctly
The soleus pushup is simpler than its name suggests, but form matters for engaging the correct muscle rather than the gastrocnemius or the tibialis anterior. The critical distinction is the position of the knee during the movement.
Seated with both feet flat on the floor and knees bent at approximately 90 degrees, the movement begins by raising the heel off the floor while keeping the ball of the foot planted. The knee tracks slightly forward over the foot as the heel lifts. At the top of the movement, the heel is fully raised and the soleus is fully contracted. The heel then lowers back to the floor, and the cycle repeats. The gastrocnemius, which crosses both the knee and ankle joints, is minimally activated when the knee is bent, isolating the soleus, which crosses only the ankle. [1] This anatomical detail is the reason the seated position is essential: standing calf raises primarily recruit the gastrocnemius, a more glycolytic muscle, reducing the metabolic advantage.
In the Hamilton study, participants performed the movement at a self-selected pace without external resistance, suggesting that even unloaded repetitions produce significant metabolic effects. The movement can be performed continuously during meetings, while eating, or at a desk, and it generates no perceptible movement visible above the table surface. Heart rate does not increase meaningfully during the movement, consistent with the muscle's oxidative, low-tension mode of operation.
For metabolic benefit, the timing is important. Performing the soleus pushup during the postprandial window, starting within 30 minutes of a meal and continuing for 60 to 90 minutes, targets the period of peak glucose excursion. The study's 270-minute protocol was chosen to test the ceiling of the effect, not to prescribe a clinical duration; shorter bouts during the postprandial window likely capture a substantial portion of the benefit.
Implications for Insulin Resistance, Prediabetes, and Metabolic Aging
Insulin resistance does not announce itself dramatically. It develops gradually over years, driven by chronic postprandial hyperglycemia, excess adiposity, low physical activity, and poor sleep, each of which compounds the others in a self-reinforcing cycle. By the time fasting glucose becomes elevated or HbA1c creeps above 5.7%, significant pathology is already present in the vasculature and beta cells. [7] This is why strategies that address postprandial glucose specifically, rather than waiting for fasting glucose to signal the problem, are gaining traction in preventive medicine.
The soleus pushup sits squarely within this preventive framework. For individuals with prediabetes or early metabolic syndrome, the ability to blunt meal-related glucose spikes through a simple, sustainable behavior represents a meaningful intervention. The effect size observed in the Hamilton study was present in otherwise healthy adults, not only in people with metabolic disease, suggesting that the muscle's glucose-clearing capacity is available across a broad population. [1]
Metabolic aging compounds the relevance. With advancing age, insulin sensitivity declines progressively, driven by sarcopenia (age-related muscle loss), increased visceral adiposity, and reduced mitochondrial function in existing muscle tissue. [2] Muscles that are rarely used atrophy: the soleus, which in most sedentary adults is contracted primarily during walking and standing, receives little stimulus in a desk-bound lifestyle. Regular soleus pushup practice could represent a form of targeted metabolic training for a muscle that otherwise goes chronically underutilized in modern sedentary life.
For individuals using continuous glucose monitors, the postprandial glucose-blunting effect of the soleus pushup is likely visible in real time. A CGM Metabolic Protocol can transform what would otherwise be an abstract recommendation into a concrete, visible feedback loop: the glucose trace after a meal with a soleus pushup session looks measurably different from the trace without one. This kind of immediate biofeedback dramatically improves adherence and helps individuals identify which meals and which behaviors produce the greatest metabolic perturbation.
The Broader Landscape of Non-Exercise Activity Thermogenesis and Metabolic Health
The soleus pushup fits within a larger scientific conversation about non-exercise activity thermogenesis, or NEAT, the energy expenditure associated with all movement that is not formal exercise. NEAT includes fidgeting, posture maintenance, and low-level limb movements, and it varies dramatically between individuals, accounting for differences in daily caloric expenditure of up to 2,000 kilocalories. [13] People who are naturally "fidgety" have significantly lower rates of obesity than matched sedentary individuals, and the mechanism is partly energetic and partly metabolic.
Research from James Levine at the Mayo Clinic established that lean individuals spend, on average, 152 more minutes per day standing and moving in low-level activity compared to obese individuals, and that these differences account for a substantial fraction of the body weight gap between groups. [13] The soleus pushup can be understood as a deliberate, targeted form of NEAT: a way of recreating the low-level muscular activity that human bodies were designed to perform throughout the day but that modern sedentary environments have nearly eliminated.
This framing is important because it shifts the conversation from "exercise as medicine" to "movement architecture as health infrastructure." The question becomes not just how to fit more formal exercise into a schedule, but how to design the daily environment so that metabolically beneficial muscle activity happens continuously and automatically, as it did throughout most of human evolutionary history. The soleus pushup, practiced consistently at meals and during sedentary work, represents one small but concrete step toward rebuilding that architecture.
Individuals engaged in comprehensive metabolic management, whether through lifestyle optimization, GLP-1 Longevity Care, the SGLT2 Protocol, or Longevity Optimization programs, stand to benefit from stacking the soleus pushup onto their existing protocols. The mechanisms are distinct and complementary. GLP-1 receptor agonists slow gastric emptying and enhance insulin secretion; SGLT2 inhibitors force renal glucose excretion; and the soleus pushup activates contraction-stimulated muscle glucose uptake. These are not redundant pathways. They address postprandial glucose through three separate angles simultaneously.
Limitations, Open Questions, and the Road Ahead
Intellectual honesty demands a clear-eyed assessment of what this science can and cannot yet support. The Hamilton 2022 study is a proof-of-concept trial: rigorous, well-measured, and mechanistically coherent, but limited to an acute metabolic response in a relatively small and healthy cohort. Several questions remain unanswered by the existing evidence.
First, there are no long-term randomized controlled trials demonstrating that regular soleus pushup practice over weeks or months improves HbA1c, fasting glucose, or cardiovascular outcomes. The acute effect on postprandial glucose is compelling, but chronic metabolic benefit requires sustained practice and longitudinal evidence. Given the simplicity of the intervention, such trials should be feasible and are worth conducting.
Second, the study did not systematically characterize individual variability in response. Glucose and insulin responses to the same meal vary considerably between people based on gut microbiome composition, baseline insulin sensitivity, muscle mass, and meal composition. [14] It is plausible that individuals with greater soleus muscle mass, higher mitochondrial density, or better baseline metabolic health show larger effects; equally plausible is that those with more severe insulin resistance, who have the most to gain, may respond differently. Precision metabolic medicine will ultimately need to characterize who benefits most.
Third, the optimal protocol remains undefined: the best duration, frequency, pace, and timing relative to meals have not been systematically compared. The study used a prolonged, continuous protocol; whether intermittent bouts, a common pattern in real-world use, produce equivalent effects is unknown. These are practical gaps that future research should address.
Fourth, the study used a carbohydrate-heavy oral glucose tolerance test rather than mixed meals, which include fat and protein and produce different glucose kinetics and hormonal responses. Whether the soleus pushup is equally effective at blunting glucose spikes from real-world meals requires testing with ecologically valid meal compositions.
Despite these limitations, the mechanistic rationale is sound, the acute effect size is large, the intervention has no meaningful adverse effects, and the compliance barrier is extraordinarily low. In the hierarchy of evidence, a compelling mechanism plus a large acute effect plus near-zero risk represents a strong case for adoption even before long-term trial data mature.
Conclusion: A Small Muscle with Large Stakes
The soleus pushup story is, in part, a story about how much metabolic capacity the human body has always possessed and how consistently modern life works against its activation. The soleus muscle was not designed to rest for eight hours a day while a person processes three meals. It was designed to contract continuously during the kind of low-level movement that characterized most of human history: walking, foraging, carrying, standing. The desk, the car, and the couch have systematically removed the stimulus that kept this metabolic engine running, and the downstream consequences, postprandial hyperglycemia, insulin resistance, and metabolic syndrome, are now among the leading drivers of chronic disease and premature biological aging.
What makes this finding matter beyond its novelty is the accessibility of the solution. Not everyone can run. Not everyone can lift weights. Aging, injury, joint disease, and social circumstance create real barriers to conventional exercise. A muscle contraction that can be performed invisibly, during a meal, during a work call, during a flight, in a wheelchair, asks nothing of the user except awareness and repetition. The soleus pushup does not replace exercise. But it fills the metabolic gaps between exercise sessions in a way that nothing else currently does with this quality of evidence.
The postprandial glucose spike is not an abstract number on a lab report. It is a moment of vascular stress repeated multiple times a day, every day, for decades. The cumulative burden of those spikes, measured in glycated proteins, oxidized lipids, and inflamed endothelium, is a large fraction of what we call metabolic aging. Any intervention that meaningfully reduces that burden, especially one that costs nothing and asks almost nothing, deserves a place in the longevity toolkit. The soleus pushup has earned its spot.
- Hamilton, M.T., Hamilton, D.G., & Zderic, T.W. (2022). A potent physiological method to magnify and sustain soleus oxidative metabolism improves glucose and lipid regulation. iScience, 25(9), 104869. https://doi.org/10.1016/j.isci.2022.104869
- DeFronzo, R.A., & Tripathy, D. (2009). Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care, 32(Suppl 2), S157–S163. https://doi.org/10.2337/dc09-S302
- Talbot, J., & Maves, L. (2016). Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease. Wiley Interdisciplinary Reviews: Developmental Biology, 5(4), 518–534. https://doi.org/10.1113/jphysiol.2011.217828
- Richter, E.A., & Hargreaves, M. (2013). Exercise, GLUT4, and skeletal muscle glucose uptake. Physiological Reviews, 93(3), 993–1017. https://doi.org/10.1152/ajpendo.00356.2010
- Biswas, A., Oh, P.I., Faulkner, G.E., Bajaj, R.R., Silver, M.A., Mitchell, M.S., & Alter, D.A. (2015). Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults. Annals of Internal Medicine, 162(2), 123–132. https://doi.org/10.7326/M14-1651
- Dunstan, D.W., Kingwell, B.A., Larsen, R., Healy, G.N., Cerin, E., Hamilton, M.T., Shaw, J.E., Bertovic, D.A., Zimmet, P.Z., Salmon, J., & Owen, N. (2012). Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care, 35(5), 976–983. https://doi.org/10.2337/dc11-1931
- Ceriello, A. (2005). Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes, 54(1), 1–7. https://doi.org/10.2337/dc09-9032
- Brownlee, M., & Hirsch, I.B. (2006). Glycemic variability: a hemoglobin A1c–independent risk factor for diabetic complications. JAMA, 295(14), 1707–1708. https://doi.org/10.1001/jama.295.14.1707
- Samuel, V.T., & Shulman, G.I. (2012). Mechanisms for insulin resistance: common threads and missing links. Cell, 148(5), 852–871. https://doi.org/10.1016/j.cmet.2013.06.016
- DiPietro, L., Gribok, A., Stevens, M.S., Hamm, L.F., & Rumpler, W. (2013). Three 15-min bouts of moderate postmeal walking significantly improves 24-h glycemic control in older people at risk for impaired glucose tolerance. Diabetes Care, 36(10), 3262–3268. https://doi.org/10.2337/dc13-0084
- Viollet, B., Guigas, B., Sanz Garcia, N., Leclerc, J., Foretz, M., & Andreelli, F. (2012). Cellular and molecular mechanisms of metformin: an overview. Clinical Science, 122(6), 253–270. https://doi.org/10.1016/j.metabol.2014.01.010
- Ferrannini, E., Ramos, S.J., Salsali, A., Tang, W., & List, J.F. (2010). Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes Care, 33(10), 2217–2224. https://doi.org/10.2337/dc14-0049
- Levine, J.A., Lanningham-Foster, L.M., McCrady, S.K., Krizan, A.C., Olson, L.R., Kane, P.H., Jensen, M.D., & Clark, M.M. (2005). Interindividual variation in posture allocation: possible role in human obesity. Science, 307(5709), 584–586. https://doi.org/10.1126/science.1117196
- Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., Ben-Yacov, O., Lador, D., Avnit-Sagi, T., Lotan-Pompan, M., Suez, J., Mahdi, J.A., Matot, E., Malka, G., Striem-Amit, E., Shibolet, O., Zmora, N., Pevsner-Fischer, M., Israeli, D., … Segal, E. (2015). Personalized nutrition by prediction of glycemic responses. Cell, 163(5), 1079–1094. https://doi.org/10.1016/j.cell.2015.11.001